GILD Stock Rose 5.68%, Gilead Reports ‘Positive Data’ on Remdesivir

GILD Stock Rose 5.68%, Gilead Reports ‘Positive Data’ on Remdesivir

Crypto New Media     •     April 30, 2020, 9:52 am

Crypto New Media Press Following the positive news on the remdesivir trial, Gilead stock rebounded. Yesterday, GILD closed at $83.14 per share or 5.68% up. After hours, it added another 2.29% to…

Clickbank Affiliate Marketing